Gapping up
In reaction to earnings/guidance:
- BBWI +21.5%, BV +9.7%, M +8.1%, CSCO +4.1%, DOLE +3.7%, CPA +3%, BJ +3%, SONO +2.6% (also authorizes new repurchase program of up to $100 mln; names new CFO), CLBT +2%, SQM +1.9%
Other news:
- ARDX +68% (reports FDA Advisory Committee votes that the benefits of XPHOZAH (tenapanor) outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis)
- MRNS +4.6% (has entered into a collaboration and supply agreement with Tenacia Biotechnology)
- IXHL +3.7% (provided development update for IHL-42X for obstructive sleep apnoea)
- UROY +3% (acquires U.S. Uranium Royalty Portfolio from Anfield Energy)
- CTRM +2.4% (to effect a spin-off of its tanker fleet)
- DLO +2% (responds to short seller report; says report contains "numerous inaccurate statements groundless claims and speculation")
- ARNC +1.1% (authorizes new $200 mln share repurchase program)
- ESPR +1% (names new CFO)
Analyst comments:
- THTX +8% (initiated with an Overweight at Cantor Fitzgerald; tgt $9)